| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |